Page 1 of Clinical Trials for Rituximab, 1180 Total Matches
- 1RecruitingLast Updated: January 13, 2012Condition(s): Leukemia; Acute Lymphoblastic Leukemia; ALL
- 2CompletedLast Updated: March 4, 2010Condition(s): Humoral Acute Refection of Renal Transplant; Autoimmune Diseases
- 3TerminatedLast Updated: July 21, 2009Condition(s): Graft vs Host Disease; Alogenic Hematopoietic Transplant
- 4Active, not recruitingLast Updated: December 19, 2011Condition(s): Follicular Lymphoma; Marginal Zone B-Cell Lymphoma; MALT Lymphoma; Lymphoma of Mucosa-Associated Lymphoid Tissue; Lymphoma, Small Lymphocytic; Waldenstrom Macroglobulinemia; Mantle-Cell Lymphoma
- 5RecruitingLast Updated: August 12, 2009Condition(s): Pemphigus Disease
- 6Active, not recruitingLast Updated: January 30, 2012Condition(s): Lymphoma
- 7TerminatedLast Updated: September 30, 2009Condition(s): Grafting; Renal Transplantation; Transplantation, Kidney; Chronic Allograft Nephropathy
- 8RecruitingLast Updated: May 7, 2012Condition(s): Waldenstrom's Macroglobulinemia
- 9Active, not recruitingLast Updated: June 20, 2008Condition(s): Refractory Myasthenia Gravis
- 10RecruitingLast Updated: May 21, 2012Condition(s): Non-Hodgkin's Lymphoma
- 11RecruitingLast Updated: May 17, 2012Condition(s): Lymphoma, Follicular
- 12RecruitingLast Updated: May 21, 2012Condition(s): Lymphocytic Leukemia, Chronic
- 13Not yet recruitingLast Updated: May 7, 2012Condition(s): Non-Hodgkin's Lymphoma
- 14RecruitingLast Updated: February 2, 2012Condition(s): Purpura; Idiopathic Thrombocytopenic Purpura
- 15TerminatedLast Updated: March 17, 2011Condition(s): Lymphoma, Non-Hodgkin's
- 16RecruitingLast Updated: July 15, 2011Condition(s): Lymphoma
- 17Active, not recruitingLast Updated: February 1, 2012Condition(s): Diffuse Large Cell Lymphoma; Lymphoma
- 18CompletedLast Updated: December 17, 2008Condition(s): Hodgkin's Disease; Leukemia; Myelodysplastic Syndrome; Non-Hodgkin's Lymphoma
- 19RecruitingLast Updated: April 23, 2012Condition(s): Follicular Lymphoma
- 20RecruitingLast Updated: January 12, 2011Condition(s): Diffuse Large B Cell Lymphoma
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Rituximab
